You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Lilly

since 2025 › Jan › 20 (Mon) @ 06:46 UTC

auto-detected in 91 stories

6 days ago

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

found 2025 › Dec › 01 (Mon) @ 13:25 UTC

The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.

13 days ago

Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here? ⊕

found 2025 › Nov › 24 (Mon) @ 18:10 UTC

a story from CNBC ⚠️ › Top News

Eli Lilly's stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner, despite its rising valuation.

16 days ago

Eli Lilly tops $1 trillion — plus, how a Fed head threw the market a lifeline ⊕

found 2025 › Nov › 21 (Fri) @ 17:30 UTC

a story from CNBC ⚠️ › Top News

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Eli Lilly becomes first pharma firm to join $1 trillion club ⊕

found 2025 › Nov › 21 (Fri) @ 17:30 UTC

a story from Al Jazeera 🚨 › Al Jazeera English

The company's stock has zoomed this year, driven by the explosive growth of the weight-loss drug market.

Eli Lilly hits $1 trillion market value, a first for a health-care company

found 2025 › Nov › 21 (Fri) @ 15:30 UTC

a story from CNBC ⚠️ › Top News

The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.

Eli Lilly becomes first pharma group to join $1tn club ⊕

found 2025 › Nov › 21 (Fri) @ 15:30 UTC

a story from Financial Times ✅ › Financial Times

Shares have soared more than 40% this year over strong demand for weight-loss and diabetes drugs

31 days ago

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study ⊖

found 2025 › Nov › 06 (Thu) @ 12:05 UTC

a story from CNBC ⚠️ › Top News

The highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.

33 days ago

Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment ⊕

found 2025 › Nov › 05 (Wed) @ 04:05 UTC

a story from Politico EU ✅ › Politico EU

Comments from medicines firm Eli Lilly will be a blow to British officials, who are in advanced negotiations with the Trump administration to secure tariff relief.

38 days ago

Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕

found 2025 › Oct › 30 (Thu) @ 16:30 UTC

a story from Financial Times ✅ › Financial Times

Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap

Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

found 2025 › Oct › 30 (Thu) @ 11:05 UTC

a story from CNBC ⚠️ › World News

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.

page 1 of 10 next → last →|